Home > Products > CEA & GD2
> Recombinant Anti-CEA x Anti-GD2 Bispecific Antibody (scIgG)
Recombinant Anti-CEA x Anti-GD2 Bispecific Antibody (scIgG) (CAT#: SCIGG-138)
Recombinant Anti-CEA x Anti-GD2 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CEA and anti-GD2 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can bind two factors simultaneously. It is designed for the research of Neuroblastoma; Osteosarcoma; Melanoma; Solid tumors therapy.
There are currently no customer reviews or questions for Recombinant Anti-CEA x Anti-GD2 Bispecific Antibody (scIgG) (SCIGG-138). Click the button below to contact us or submit your feedback about this product.